Found: 1296
Select item for more details and to access through your institution.
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49444-1
- By:
- Publication type:
- Article
Multi-omics analysis reveals the dynamic interplay between Vero host chromatin structure and function during vaccinia virus infection.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06389-x
- By:
- Publication type:
- Article
Alaskapox virus, an emerging Orthopoxvirus in the Arctic region.
- Published in:
- International Journal of Dermatology, 2024, v. 63, n. 6, p. e115, doi. 10.1111/ijd.17152
- By:
- Publication type:
- Article
Proteomic analysis of plasma in healthy adults receiving recombinant vaccinia virus provides novel insights into HIV‐1 neutralizing antibodies.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 6, p. 1, doi. 10.1002/jmv.29749
- By:
- Publication type:
- Article
Vaccinia Virus: Mechanisms Supporting Immune Evasion and Successful Long-Term Protective Immunity.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 6, p. 870, doi. 10.3390/v16060870
- By:
- Publication type:
- Article
Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48312-2
- By:
- Publication type:
- Article
Structure and flexibility of the DNA polymerase holoenzyme of vaccinia virus.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 5, p. 1, doi. 10.1371/journal.ppat.1011652
- By:
- Publication type:
- Article
A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1372584
- By:
- Publication type:
- Article
The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1360140
- By:
- Publication type:
- Article
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 256, doi. 10.1159/000533650
- By:
- Publication type:
- Article
Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1277447
- By:
- Publication type:
- Article
The Recombinant Oncolytic Virus VV-GMCSF-Lact and Chemotherapy Drugs against Human Glioma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 8, p. 4244, doi. 10.3390/ijms25084244
- By:
- Publication type:
- Article
Enhancing the efficacy of vaccinia-based oncolytic virotherapy by inhibiting CXCR2-mediated MDSC trafficking.
- Published in:
- Journal of Leukocyte Biology, 2024, v. 115, n. 4, p. 633, doi. 10.1093/jleuko/qiad150
- By:
- Publication type:
- Article
Hesperetin blocks poxvirus replication with a low tendency to select for drug‐resistant viral variants.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 4, p. 1, doi. 10.1002/jmv.29555
- By:
- Publication type:
- Article
Recent progress in combination therapy of oncolytic vaccinia virus.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1272351
- By:
- Publication type:
- Article
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00833-z
- By:
- Publication type:
- Article
Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.
- Published in:
- Science Translational Medicine, 2024, v. 17, n. 740, p. 1, doi. 10.1126/scitranslmed.adl4317
- By:
- Publication type:
- Article
Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0298437
- By:
- Publication type:
- Article
A comprehensive approach for evaluating the virucidal performance of domestic laundry detergents under practical conditions.
- Published in:
- Journal of Applied Microbiology, 2024, v. 135, n. 3, p. 1, doi. 10.1093/jambio/lxae052
- By:
- Publication type:
- Article
Differing Susceptibilities to Certain Microbicidal Chemistries among Three Representative Enveloped Viruses.
- Published in:
- Microorganisms, 2024, v. 12, n. 3, p. 535, doi. 10.3390/microorganisms12030535
- By:
- Publication type:
- Article
Identification of a Potential Entry-Fusion Complex Based on Sequence Homology of African Swine Fever and Vaccinia Virus.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 3, p. 349, doi. 10.3390/v16030349
- By:
- Publication type:
- Article
Fast and Ultrasensitive Detection of Monkeypox by a Pyrococcus furiosus Argonaute System Coupled with a Short Amplification.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 3, p. 382, doi. 10.3390/v16030382
- By:
- Publication type:
- Article
γδ T Cells Mediate a Requisite Portion of a Wound Healing Response Triggered by Cutaneous Poxvirus Infection.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 3, p. 425, doi. 10.3390/v16030425
- By:
- Publication type:
- Article
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-01946-8
- By:
- Publication type:
- Article
Transgene expression knockdown in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1338492
- By:
- Publication type:
- Article
Characterizing Aptamer Interaction with the Oncolytic Virus VV-GMCSF-Lact.
- Published in:
- Molecules, 2024, v. 29, n. 4, p. 848, doi. 10.3390/molecules29040848
- By:
- Publication type:
- Article
Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 2, p. 321, doi. 10.3201/eid3002.230542
- By:
- Publication type:
- Article
Vaccinia Virus Defective Particles Lacking the F17 Protein Do Not Inhibit Protein Synthesis: F17, a Double-Edged Sword for Protein Synthesis?
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1382, doi. 10.3390/ijms25031382
- By:
- Publication type:
- Article
PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcinoma.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03238-z
- By:
- Publication type:
- Article
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-023-00801-z
- By:
- Publication type:
- Article
Oncolytic vaccinia virus and cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1324744
- By:
- Publication type:
- Article
Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 1, p. 54, doi. 10.1093/infdis/jiad245
- By:
- Publication type:
- Article
Characterizing the acute antibody response of monkeypox and MVA‐BN vaccine following an Australian outbreak.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 1, p. 1, doi. 10.1002/jmv.29407
- By:
- Publication type:
- Article
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 52, doi. 10.3390/vaccines12010052
- By:
- Publication type:
- Article
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 105, doi. 10.3390/vaccines12010105
- By:
- Publication type:
- Article
Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein.
- Published in:
- Virology Journal, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12985-023-02264-z
- By:
- Publication type:
- Article
Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.
- Published in:
- PLoS Neglected Tropical Diseases, 2023, v. 17, n. 12, p. 1, doi. 10.1371/journal.pntd.0011851
- By:
- Publication type:
- Article
The Global Health Threat of Monkeypox Virus: Understanding Its Biology, Transmission, and Potential Therapeutic Interventions.
- Published in:
- Infection & Drug Resistance, 2023, v. 16, p. 7759, doi. 10.2147/IDR.S438725
- By:
- Publication type:
- Article
Case study: breakthrough mpox infection in Aotearoa New Zealand and Australia after completed two-dose course of subcutaneous modified vaccinia Ankara (MVA-BN) vaccines.
- Published in:
- Sexual Health (14485028), 2023, v. 20, n. 6, p. 585, doi. 10.1071/SH23139
- By:
- Publication type:
- Article
The Antiviral Effect of Berdazimer Sodium on Molluscum Contagiosum Virus Using a Novel In Vitro Methodology.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 12, p. 2360, doi. 10.3390/v15122360
- By:
- Publication type:
- Article
Neutralization Determinants on Poxviruses.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 12, p. 2396, doi. 10.3390/v15122396
- By:
- Publication type:
- Article
Extraction-free LAMP assays for generic detection of Old World Orthopoxviruses and specific detection of Mpox virus.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48391-z
- By:
- Publication type:
- Article
A highly efficient scheme for library preparation from single-stranded DNA.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40890-3
- By:
- Publication type:
- Article
Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 22, p. 2616, doi. 10.3390/cells12222616
- By:
- Publication type:
- Article
Structural and functional analysis of vaccinia viral fusion complex component protein A28 through NMR and molecular dynamic simulations.
- Published in:
- PLoS Pathogens, 2023, v. 19, n. 11, p. 1, doi. 10.1371/journal.ppat.1011500
- By:
- Publication type:
- Article
Functional epitopes and neutralizing antibodies of vaccinia virus.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1255935
- By:
- Publication type:
- Article
Zoonotic risks of pathogens from dairy cattle and their milk-borne transmission.
- Published in:
- Journal of Dairy Research, 2023, v. 90, n. 4, p. 325, doi. 10.1017/S0022029923000730
- By:
- Publication type:
- Article
Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad528
- By:
- Publication type:
- Article
Serosurvey of Immunity to Monkeypox (Mpox) Virus Antigens in People Living with HIV in South Florida.
- Published in:
- Pathogens, 2023, v. 12, n. 11, p. 1355, doi. 10.3390/pathogens12111355
- By:
- Publication type:
- Article
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1663, doi. 10.3390/vaccines11111663
- By:
- Publication type:
- Article